Melanoma: What do all the mutations mean?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Melanoma: What do all the mutations mean?

Published:2018-04-17 Issue:17 Volume:124 Page:3490-3499
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Davis Elizabeth J.¹,Johnson Douglas B.¹^ORCID,Sosman Jeffrey A.²,Chandra Sunandana²^ORCID

Affiliation:

1. Department of Medicine; Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center; Nashville Tennessee

2. Department of Medicine; Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center; Chicago Illinois

Funder

National Institutes of Health

Melanoma Research

NIH Clinical Center

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.31345/fullpdf

Reference94 articles.

1. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib;Sosman;N Engl J Med,2012

2. Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence;Mitsudomi;J Clin Oncol,2005

3. Crizotinib in ROS1-rearranged non-small-cell lung cancer;Shaw;N Engl J Med,2014

4. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N Engl J Med,2013

5. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial;Verweij;Lancet,2004

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing cardiac glycosides for anticancer treatment: a review of clinical studies;Drug Discovery Today;2024-10

2. Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- (“Triple”) wild type melanomas;European Journal of Cancer;2024-09

3. Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma;Cancer Treatment Reviews;2024-09

4. Gender and melanoma subtype‐based prognostic implications of MUC16 and TTN co‐occurrent mutations in melanoma: A retrospective multi‐study analysis;Cancer Medicine;2024-09

5. Molecular Susceptibility and Treatment Challenges in Melanoma;Cells;2024-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3